Patents Assigned to DERMTECH, INC.
  • Gene classifiers and uses thereof in non-melanoma skin cancers
    Patent number: 11976332
    Abstract: Described herein are methods, systems, and compositions for non-invasively diagnosing or detecting a skin disease or disorder. Diagnosing or detecting a non-melanoma skin cancer as provided herein comprises detecting gene expression levels of a set of identified genes and in some instances further detecting mutations in a gene of interest.
    Type: Grant
    Filed: February 14, 2019
    Date of Patent: May 7, 2024
    Assignee: DERMTECH, INC.
    Inventors: John Daniel Dobak, III, Burkhard Jansen, Zuxu Yao
  • Diagnosis of melanoma and solar lentigo by nucleic acid analysis
    Patent number: 11753687
    Abstract: The present invention provides methods for diagnosing melanoma and/or solar lentigo in a subject by analyzing nucleic acid molecules obtained from the subject. The present invention also provides methods for distinguishing melanoma from solar lentigo and/or dysplastic nevi and/or normal pigmented skin. The methods include analyzing expression or mutations in epidermal samples, of one or more skin markers. The methods can include the use of a microarray to analyze gene or protein profiles from a sample.
    Type: Grant
    Filed: March 8, 2021
    Date of Patent: September 12, 2023
    Assignee: DERMTECH, INC.
    Inventor: Sherman H. Chang
  • Methods for diagnosing atopic dermatitis using gene classifiers
    Patent number: 11643689
    Abstract: Disclosed herein are methods of detecting an altered gene expression levels in a subject suspected of having atopic dermatitis. Further described herein are methods of treating atopic dermatitis in a subject having an exhibiting an altered gene expression level.
    Type: Grant
    Filed: March 26, 2021
    Date of Patent: May 9, 2023
    Assignee: DERMTECH, INC.
    Inventors: John Daniel Dobak, III, Burkhard Jansen, Zuxu Yao
  • Gene classifiers and uses thereof in skin cancers
    Patent number: 11578373
    Abstract: Disclosed herein, in certain embodiments, are methods of detecting the presence of a skin cancer based on molecular risk factors. In some instances, the skin cancer is cutaneous T cell lymphoma (CTCL). In some cases, the skin cancer is mycosis fungoides (MF) or Sézary syndrome (SS).
    Type: Grant
    Filed: March 24, 2020
    Date of Patent: February 14, 2023
    Assignee: DermTech, Inc.
    Inventors: John Daniel Dobak, III, Burkhard Jansen, Zuxu Yao
  • Diagnosis of melanoma and solar lentigo by nucleic acid analysis
    Patent number: 11332795
    Abstract: The present invention provides methods for diagnosing melanoma and/or solar lentigo in a subject by analyzing nucleic acid molecules obtained from the subject. The present invention also provides methods for distinguishing melanoma from solar lentigo and/or dysplastic nevi and/or normal pigmented skin. The methods include analyzing expression or mutations in epidermal samples, of one or more skin markers. The methods can include the use of a microarray to analyze gene or protein profiles from a sample.
    Type: Grant
    Filed: July 25, 2019
    Date of Patent: May 17, 2022
    Assignee: DERMTECH, INC.
    Inventor: Sherman H. Chang
  • Non-invasive skin collection system
    Patent number: 10709428
    Abstract: The subject matter described herein provides non-invasive tape stripping methods for the collection of a skin sample. The tape stripping method includes applying and removing at least one adhesive tape, provided that a skin sample is adhered to the adhesive tape after removal. The at least one adhesive tape is supplied in an adhesive skin sample collection kit. The adhesive skin sample collection kit further comprises a sample collector and instructions for use sheet.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: July 14, 2020
    Assignee: DERMTECH, INC.
    Inventors: Tara J. Palmer, John P. Alsobrook, II, John Dobak
  • Diagnosis of melanoma by nucleic acid analysis
    Patent number: 10407729
    Abstract: The present invention provides methods for diagnosing melanoma and/or solar lentigo in a subject by analyzing nucleic acid molecules obtained from the subject. The present invention also provides methods for distinguishing melanoma from solar lentigo and/or dysplastic nevi and/or normal pigmented skin. The methods include analyzing expression or mutations in epidermal samples, of one or more skin markers. The methods can include the use of a microarray to analyze gene or protein profiles from a sample.
    Type: Grant
    Filed: August 21, 2015
    Date of Patent: September 10, 2019
    Assignee: DERMTECH, INC.
    Inventor: Sherman H. Chang
  • Computer display panel with a graphical user interface for a dermatology report
    Patent number: D966299
    Type: Grant
    Filed: February 16, 2021
    Date of Patent: October 11, 2022
    Assignee: DERMTECH, INC.
    Inventors: John Daniel Dobak, III, Sarah Dion, Burkhard Jansen, Jane Bue
  • Computer display panel with a graphical user interface for a dermatology report
    Patent number: D966300
    Type: Grant
    Filed: February 16, 2021
    Date of Patent: October 11, 2022
    Assignee: DERMTECH, INC.
    Inventors: John Daniel Dobak, III, Sarah Dion, Burkhard Jansen, Jane Bue, Claudia Ibarra
  • Dermatology report document
    Patent number: D988399
    Type: Grant
    Filed: February 16, 2021
    Date of Patent: June 6, 2023
    Assignee: DERMTECH, INC.
    Inventors: John Daniel Dobak, III, Sarah Dion, Burkhard Jansen, Jane Bue, Claudia Ibarra
  • Dermatology report document
    Patent number: D989861
    Type: Grant
    Filed: February 16, 2021
    Date of Patent: June 20, 2023
    Assignee: DERMTECH, INC.
    Inventors: John Daniel Dobak, III, Sarah Dion, Burkhard Jansen, Jane Bue